BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 14746241)

  • 41. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.
    Laufman LR; Forsthoefel KF
    Clin Breast Cancer; 2001 Oct; 2(3):235. PubMed ID: 11899418
    [No Abstract]   [Full Text] [Related]  

  • 42. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
    Yoshida S; Morii K
    Surg Neurol; 2005 Jan; 63(1):52-5; discussion 55. PubMed ID: 15639526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy.
    Chamberlain MC; Kormanik PR
    J Neurooncol; 1997 Oct; 35(1):55-64. PubMed ID: 9266441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
    Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports.
    Meissner M; Addeo A
    Case Rep Oncol; 2016; 9(3):586-592. PubMed ID: 27920689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder].
    Hara Y; Kobayashi Y; Goto K; Tozuka K; Tokue A; Mochizuki M
    Hinyokika Kiyo; 1994 Dec; 40(12):1113-7. PubMed ID: 7863865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carcinomatous meningitis in solid tumours.
    Jayson GC; Howell A
    Ann Oncol; 1996 Oct; 7(8):773-86. PubMed ID: 8922190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinomatous meningitis: clinical manifestations and management.
    Zachariah B; Zachariah SB; Varghese R; Balducci L
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):7-12. PubMed ID: 7711996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
    Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracranial dural metastases.
    Nayak L; Abrey LE; Iwamoto FM
    Cancer; 2009 May; 115(9):1947-53. PubMed ID: 19241421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinomatous meningitis from urachal carcinoma: the first reported case.
    McClelland S; Garcia RE; Monaco SE; Goldman JE; Olson TJ; Kim GH; Petrylak DP; Goodman RR
    J Neurooncol; 2006 Jan; 76(2):171-4. PubMed ID: 16307300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meningeal carcinomatosis in breast cancer.
    Yap HY; Yap BS; Tashima CK; DiStefano A; Blumenschein GR
    Cancer; 1978 Jul; 42(1):283-6. PubMed ID: 667799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.
    Sakai M; Ishikawa S; Ito H; Ozawa Y; Yamamoto T; Onizuka M; Sakakibara Y
    Int J Clin Oncol; 2006 Jun; 11(3):243-5. PubMed ID: 16850132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seasonal variability in the incidence of carcinomatous meningitis.
    Koutras A; Sakellakis M; Makatsoris T; Psachoulia C; Kardari M; Nikolakopoulos A; Gogos C; Kalofonos HP
    J Neurosurg; 2015 Mar; 122(3):543-6. PubMed ID: 25574572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leptomeningeal metastasis from solid tumors.
    Thakkar JP; Kumthekar P; Dixit KS; Stupp R; Lukas RV
    J Neurol Sci; 2020 Apr; 411():116706. PubMed ID: 32007755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
    Rudnicka H; Niwińska A; Murawska M
    J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer.
    Schabet M; Kloeter I; Adam T; Heidemann E; Wiethölter H
    Eur Neurol; 1986; 25(6):403-11. PubMed ID: 3792399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinomatous meningitis in cancer of the uterine cervix.
    Rentinck ME; Schrijver HM; Kneppers E; Zijlmans JC; van Groeningen CJ
    J Neurooncol; 2004 Oct; 70(1):87-90. PubMed ID: 15527113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.